109170 ⎘
Structure or type of the nucleic acid; Chemical structure of the sugar 2'-O-R Modification
Antisense Modulation Of Amyloid Beta Protein Expression
#3002Modulation of glucose-6-phosphatase translocase expression
#3003Organic compositions to treat HSF1-related diseases
#3004Anti-MicroRNA oligonucleotide molecules
#30055′ triphosphate oligonucleotide with blunt end and uses thereof
#3006Modulation of CD40 expression
#3007RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
#3008Chimeric Molecules to Modulate Gene Expression
#3009Bispecific oligonucleotide for the treatment of CNS malignancies
#3010Double-stranded polynucleotide
#3011SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION
#3012Modulation of SMRT expression
#3013Compositions and methods for inhibiting expression of XBP-1 gene
#3014COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES
#3015TOLL-LIKE RECEPTOR 9 AGONISTS FOR THE TREATMENT OF ANXIETY-RELATED DISORDERS AND INFLAMMATORY DISORDERS
#3016Compositions and their uses directed to acetyl-CoA carboxylases
#3017SYNTHETIC AGONISTS OF TLR9
#3018NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF
#3019Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#3020COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
#3021Methods and compositions for reducing viral genome amounts in a target cell
#3022Materials and Methods for Treatment of Cancer
#3023Methods for modulating expression of RBP4
#3024Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes
#3025Interfering RNA molecules
#3026DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES
#3027Antisense antiviral compound and method for treating influenza viral infection
#3028Antisense modulation of C-reactive protein expression
#3029Therapeutic uses of inhibitors of RTP801
#3030RNA interference mediating small RNA molecules
#3031Compositions and methods for inhibiting expression of IKK-B gene
#3032Compositions and their uses directed to PTPRU
#3033Double-stranded RNA directed to CASP2 and methods of use thereof
#3034MODULATION OF LDL RECEPTOR GENE EXPRESSION WITH DOUBLE-STRANDED RNAS TARGETING THE LDL RECEPTOR GENE PROMOTER
#3035SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#3036siRNA compounds for inhibiting NRF2
#3037Compositions and their uses directed to gemin genes
#3038ANTISENSE MODULATION OF BCL2-ASSOCIATED X PROTEIN EXPRESSION
#3039Modification of MYD88 splicing using modified oligonucleotides
#3040METHOD OF TREATING NEURODEGENERATIVE DISEASE
#3041COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF
#3042RNA antagonist compounds for the modulation of PIK3CA expression
#3043Lipid formulations for nucleic acid delivery
#3044MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#3045RNAi Modulation of the RHO-A Gene and Uses Thereof
#3046RNA interference mediating small RNA molecules
#3047RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#3048Compounds and methods for modulating expression of SGLT2
#3049RNA interference mediating small RNA molecules
#3050RNA interference mediating small RNA molecules
#3051Compositions and methods for inhibiting expression of a gene from the ebola virus
#3052Modulation of apolipoprotein C-III expression
#3053Aptamer therapeutics useful in the treatment of complement-related disorders
#3054MODULATION OF FACTOR 9 EXPRESSION
#3055Therapeutic compositions
#3056RNA interference mediating small RNA molecules
#3057Method for reducing scarring during wound healing using antisense compounds directed to CTGF
#3058Antisense oligonucleotide modulation of STAT3 expression
#3059DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#3060Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3061Use of antisense oligonucleotides to effect translation modulation
#3062Modified RNAi polynucleotides and uses thereof
#3063Modulation of apolipoprotein (a) expression
#3064Chimeric oligomeric compounds for modulation of splicing
#3065CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE
#3066Compositions and methods for inhibiting expression of CD45 gene
#3067Modulation of T cell signaling threshold and T cell sensitivity to antigens
#3068Methods of treating eye diseases in diabetic patients
#3069RNA interference mediating small RNA molecules
#3070Methods and Compositions for Treating Neurological Disease
#3071Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
#3072TRPM-2 antisense therapy
#3073RNA interference mediating small RNA molecules
#3074Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3075Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3076Lipid formulated dsRNA targeting the PCSK9 gene
#3077RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
#3078COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE
#3079RNA interference mediating small RNA molecules
#3080RNAi probes targeting cancer-related proteins
#3081Methods and compositions for inhibition of immune responses and autoimmunity
#3082Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof
#3083Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#3084Antidotes to antisense compounds
#3085EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#3086METHODS AND COMPOSITONS FOR ANTISENSE VEGF OLIGONUCLEOTIDES
#3087Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon
#3088Modulation of SGLT2 expression
#3089Lipid formulation
#3090RNA Antagonist Compounds for the Modulation of MCL-1
#3091Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#3092MODULATION OF HIF1 BETA EXPRESSION
#3093RNA interference mediating small RNA molecules
#3094Modulation of forkhead box O1A expression
#3095Nucleic acid modulators of glycoprotein VI
#3096Modulation of stat5 expression
#3097RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
#3098RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA
#3099Antibodies directed to mGluR7
#3100Modulation of factor 7 expression
#3101MicromiRs
#3102Compositions and methods for inhibiting expression of Huntingtin gene
#3103Administering antisense oligonucleotides complementary to human apolipoprotein B
#3104RNA interference mediating small RNA molecules
#3105RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
#3106Compounds and methods for improving cellular uptake of oligomeric compounds
#3107NOVEL SIRNA STRUCTURES
#3108Micrornas that regulate muscle cell proliferation and differentiation
#3109Antisense modulation of fibroblast growth factor receptor 4 expression
#3110Anti-microRNA oligonucleotide molecules
#3111Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor
#3112Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
#3113Micro-RNA family that modulates fibrosis and uses thereof
#3114Combination treatment for the treatment of hepatitis C virus infection
#3115RECEPTOR TARGETED OLIGONUCLEOTIDES
#3116METHODS AND COMPOSITIONS FOR MODULATING TISSUE FACTOR
#3117Modulation of apolipoprotein (A) expression
#3118Therapeutic uses of inhibitors of RTP801
#3119Targeting microRNAs for the treatment of liver cancer
#3120Method for inhibiting the activity of mir-155
#3121RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
#3122METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#3123Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
#3124Rnai Therapeutic for Respiratory Virus Infection
#3125Modulators of pharmacological agents
#3126Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#3127DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS
#3128Therapeutic compositions
#3129Antisense modulation of kinesin-like 1 expression
#3130RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
#3131MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#3132RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3133Compositions and methods for inhibiting expression of a gene from the JC virus
#3134RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)
#3135RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3136siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
#3137Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof
#3138MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION
#3139Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
#3140RNAi inhibition of alpha-ENaC expression
#3141RNAi inhibition of alpha-ENaC expression
#3142AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL
#3143RNAi modulation of APOB and uses thereof
#3144Compositions and methods for modulation of SMN2 splicing
#3145RNAi inhibition of alpha-ENaC expression
#3146RNAi inhibition of alpha-ENaC expression
#3147METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCV
#3148Nicked or gapped nucleic acid molecules and uses thereof
#3149OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#3150Compositions and methods for inhibiting expression of the HAMP gene
#3151Method of Treating Neurodegenerative Disease
#3152INFLUENZA THERAPEUTIC
#3153Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
#3154Modulators of coagulation factors
#3155ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#3156RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3157Antisense compounds
#3158MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE
#31595'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
#3160RNAi inhibition of alpha-ENaC expression
#3161EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
#3162METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS
#3163RNAi modulation of SCAP and therapeutic uses thereof
#3164RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
#3165RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
#3166dsRNA For Treating Viral Infection
#3167Compositions and methods for modulating angiogenesis
#3168COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE
#3169dsRNA FOR TREATING VIRAL INFECTION
#3170ANTIVIRAL OLIGONUCLEOTIDES TARGETING RSV
#3171Extended dicer substrate agents and methods for the specific inhibition of gene expression
#3172Enhanced biotherapeutic production using inhibitory RNA
#3173ANTIVIRAL OLIGONUCLEOTIDES TARGETING VIRAL FAMILIES
#3174Oligomers
#3175RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#3176GNAQ targeted dsRNA compositions and methods for inhibiting expression
#3177Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules
#3178Therapeutic uses of inhibitors of RTP801L
#3179MODULATION OF SID-1 EXPRESSION
#3180RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3181OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA
#3182OLIGONUCLEOTIDE SYSTEMS FOR TARGETED INTRACELLULAR DELIVERY
#3183RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis
#3184Methods for treating hypercholesterolemia
#3185Modulation of factor 11 expression
#3186RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3187DOUBLE-STRANDED OLIGONUCLEOTIDES
#3188Pure miRNA Sample Preparation Method
#3189Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
#3190RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)
#3191Multiple exon skipping compositions for DMD
#3192MODULATION OF eIF4E EXPRESSION
#3193Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
#3194COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES
#3195RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3196Compositions and methods for inhibiting expression of transthyretin
#3197Methods for treating multiple sclerosis using antisense oligonucleotides
#3198Modulation of HIF1-beta expression
#3199RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
#3200Therapeutic targets and molecules
#3201NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOF
#3202RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#3203RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
#3204RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#3205Compositions and methods for gene silencing
#3206Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
#3207MODULATION OF MYELOID DIFFERENTATION PRIMARY RESPONSE GENE 88 (MYD88) EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES
#3208METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME
#3209Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
#3210METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION
#3211COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#3212Hydroxymethyl substituted RNA oligonucleotides and RNA complexes
#3213Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha
#3214NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
#3215MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES
#3216EFFICIENT REDUCTION OF TARGET RNA'S BY SINGLE- AND DOUBLE-STRANDED OLIGOMERIC COMPOUNDS
#3217Method of treating a cancer by administering A 2′,5′-oligoadenylate analog
#3218Antisense modulation of connective tissue growth factor expression
#3219Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#3220Compositions and their uses directed to PTPR alpha
#32212′-hydroxyl group-modified ribonucleoside derivatives
#3222Compositions and methods for inhibiting expression of the MYC gene
#3223Short interfering ribonucleic acid (siRNA) with improved pharmacological properties
#3224RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES
#3225Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene
#3226COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID
#3227Aptamer against midkine and use thereof
#3228Pharmaceutical Composition
#3229Modulation of gene expression through endogenous small RNA targeting of gene promoters
#3230Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
#3231COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP
#3232COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2
#3233ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#3234Methods for treating hypercholesterolemia
#3235Compounds and methods for modulating expression of PTP1B
#3236Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3237GENE SILENCING USING SENSE DNA AND ANTISENSE RNA HYBRID CONSTRUCTS COUPLED TO PEPTIDES FACILITATING THE UPTAKE INTO CELLS
#3238Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure
#3239Compositions and their uses directed to IL-4R alpha
#3240RNAi modulation of ApoB and uses thereof
#3241METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY
#3242Compounds and methods for modulating expression of GCCR
#3243Compounds and methods for modulating expression ApoB
#3244Compounds and methods for modulating expression of GCGR
#3245CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION
#3246Compounds and methods for modulating expression of PCSK9
#3247Means for inhibiting the expression of protein kinase 3
#3248RNA Interference Mediated Inhibition Of Interleukin and Interleukin Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3249Regulation of epigenetic control of gene expression
#3250Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3251MODULATION OF STAT 6 EXPRESSION
#3252COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2
#3253Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3254Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3255Silencing of polo-like kinase expression using interfering RNA
#3256Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
#3257Compositions and methods for delivering RNAI using lipoproteins
#3258Modulation of insulin like growth factor I receptor expression
#3259Compositions and Their Uses Directed to IL-4R Alpha
#3260Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
#3261RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
#3262STABILIZED SIRNAS AS TRANSFECTION CONTROLS AND SILENCING REAGENTS
#3263MicroRNA and methods for inhibiting same
#3264Compositions and methods for inhibiting expression of XBP-1 gene
#3265ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES
#3266Antisense modulation of C-reactive protein expression
#3267MODULATION OF TUDOR-SN EXPRESSION
#3268HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF
#3269Means and method for inducing exon-skipping
#3270Conjugates and compositions for cellular delivery
#3271Compositions and methods for inhibiting expression of factor VII gene
#3272DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSTEM
#3273COMPOSITIONS AND THEIR USES DIRECTED TO HSP27
#3274Compositions and methods for inhibiting expression of Nav1.8 gene
#3275Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
#3276RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
#3277RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3278dsRNA compositions and methods for treating HPV infection
#3279RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3280HEPATITIS C ANTIVIRALS
#3281RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3282Induction of exon skipping in eukaryotic cells
#3283Oligomeric compounds and compositions for the use in modulation of microRNAs
#3284MODULATION OF LMW-PTPASE EXPRESSION
#3285Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
#3286Duplex oligonucleotides with enhanced functionality in gene regulation
#3287COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE
#3288Compositions of asymmetric interfering RNA and uses thereof
#3289MODULATION OF SURVIVIN EXPRESSION
#3290ANTISENSE COMPOUNDS HAVING ENHANCED ANTI-MICRORNA ACTIVITY
#3291HEPATITIS C ANTIVIRALS
#3292vWF aptamer formulations and methods for use
#3293Modulation of eIF4E-BP2 expression
#3294Glycoconjugates of RNA interference agents
#3295MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS
#32962'-Modified Oligonucleotides
#3297Modified short interfering RNA
#3298Interfering RNA duplex having blunt-ends and 3′-modifications
#3299RNA antagonist compounds for the modulation of PIK3CA expression
#3300Modulation of eIF4E expression